1Delgado G, Bundy BN, Zain R, et al. Prospective Surgical Pathological study of disease free interval in patients with stage I B squamous celt carcinoma of the cervix: A Gynecologic Oncology group study. Gynecol Oncol , 1990,38:352-359.
2Yeh SA, Leung SW, Wan CJ, et al. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: Treatment results and prognostic factors.6ynecot Oncol, 1999,72 : 10-15.
3Snijders-Keilholt AS, Hellebrekers, B. W. J, Zwinderman AH, et al. Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma. Radiother Oncol, 1999,51: 161-167.
4Hong JH, Tsai CS, Lai CH, et al. Postoperative lowpelvic irradiation for stage Ⅰ-Ⅱ^A, cervical cancer patients with risk factors other than pelvic lymph node metastasis. In J Ratlation Oncol Biol Phys, 2002, 53:1289-1290.
5Sedlis A, Bundy, B. N, Rotman ME, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selectetd patients with stage 1B carcinoma of the cervix after radical hysterectomy and pelvic lymphadenect: A Gynecologic Oncology group study. Gynecol Ontol, 1999,73 : 173-183.
6Lahousen M, Haas J, Pickel H, et al. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomited, prospective, multicenter trial. Oynecol Oncol, 1999,73 : 196-201.
4Zhou Z1,Guo J,Yu H,et al. Comparison of Gd[DTPA- bis(2- aminoethoxy)ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography. experimental study with rabbits[J].J Magn Reson Imaging, 2005,22(3) 361-367.
5Dimakakos E, Koureas A, Koutoulidis V.et al. Interstitial magnetic resonance lympho- graophy:is it a new method for the diagnosis of Iymphedema?[J]. Int Angiol, 2007,26(4): 367-371.
6Misselwitz B,Schmitt-Willich H,Michaelis M,et al. lntemtitial magnetic resonance lymphography using a polymeric tl contrast agent:initial experience with Gadomer- 17[J]. Invest Radiol,2002,37(3): 146-151.
